Infliximab Therapy Inhibits Inflammation-Induced Angiogenesis in the Mucosa of Patients With Crohn's Disease

IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy

(2010) W. A. Verri et al.   ANNALS OF THE RHEUMATIC DISEASES

Extracellular matrix, inflammation, and the angiogenic response

(2010) A. G. Arroyo et al.   CARDIOVASCULAR RESEARCH

Angiogenesis and vasculogenesis in rheumatoid arthritis

(2010) Zoltán Szekanecz et al.   CURRENT OPINION IN RHEUMATOLOGY

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

(2010) A. Dignass et al.   Journal of Crohns & Colitis

The expanding role of biologic therapy for IBD

(2010) Stephen B. Hanauer   Nature Reviews Gastroenterology & Hepatology

Future biologic targets for IBD: potentials and pitfalls

(2010) Gil Y. Melmed et al.   Nature Reviews Gastroenterology & Hepatology

Intravitreal Administration of the Anti-Tumor Necrosis Factor Agent Infliximab for Neovascular Age-related Macular Degeneration

(2009) Panagiotis G. Theodossiadis et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1β production and deficient apoptosis of rheumatoid arthritis monocytes

(2009) Undine Meusch et al.   ARTHRITIS AND RHEUMATISM

VEGF-A Links Angiogenesis and Inflammation in Inflammatory Bowel Disease Pathogenesis

(2008) Franco Scaldaferri et al.   GASTROENTEROLOGY

Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition

(2008) D G Binion et al.   GUT